NOT-DA-21-070: Notice to Extend the Expiration Date for PAR-19-163, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)"

Notice to Extend the Expiration Date for PAR-19-163, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)"

Notice Number:

NOT-DA-21-070

Key Dates

Release Date:

August 3, 2021

Related Announcements

NOT-DA-21-082 - Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)

PAR-19-163 - Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)

Issued by

National Institute on Drug Abuse (NIDA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Mental Health (NIMH)

National Institute on Minority Health and Health Disparities (NIMHD)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

Purpose

The purpose of this notice is to inform interested applicants that the expiration Date for PAR-19-163 , "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)" will be extended by one Council round (changes shown in bold italics below). This Funding Opportunity Announcement has been modified to add an additional Application due date of October 16, 2021 (new applications), November 16, 2021 (resubmission applications) and an additional AIDS Application Due Date of January 7, 2022.

Currently Reads:

Part 1. Overview

Key Dates

Expiration Date: Septmeber 8, 2021

Modified to Read:

Part 1. Overview

Key Dates

Expiration Date: January 8, 2022

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Elizabeth Hoffman
National Institute on Drug Abuse (NIDA)
Telephone: 301.594.2265
Email: [email protected]